Company Profiles

driven by the PitchBook Platform

CMDBioscience

Description

Provider of computational peptide drug discovery platform. The company provides computer-aided analysis, modeling and design of therapeutic peptides.

2006

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$250k

Latest Deal Amount

$6.98M

Total Amount Raised

Description

Provider of computational peptide drug discovery platform. The company provides computer-aided analysis, modeling and design of therapeutic peptides.

Website:

www.cmdbioscience.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Vertical Market Software
Drug Discovery

Primary Office

554 Boston Post Road Suite 318 Orange, CT 06477United States +1 (203) 298-4251
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore CMDBioscience's full profile, request a free trial.

CMDBioscience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

CMDBioscience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

CMDBioscience Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Connecticut InnovationsVenture CapitalMinority000 0000000 0000
Enhanced Capital PartnersPE/BuyoutMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
LaunchCapitalVenture CapitalMinority000 0000000 0000
Mohegan TribeOtherMinority000 0000000 0000
Connecticut Innovations Venture Capital
Enhanced Capital Partners PE/Buyout
Individual Investor Angel (individual)
LaunchCapital Venture Capital
Mohegan Tribe Other

CMDBioscience Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Joseph Audie Ph.DChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
Charles Boyd Ph.DChief Investigational Scientist
David Diller Ph.DSenior Director of Computational Chemistry
Mark Jarosinski Ph.DSenior Director, Peptide Medicinal Chemistry & Business Development
Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member
Charles Boyd Ph.D Chief Investigational Scientist
David Diller Ph.D Senior Director of Computational Chemistry
Mark Jarosinski Ph.D Senior Director, Peptide Medicinal Chemistry & Business Development

CMDBioscience Board Members (4)

NameRepresentingRoleSinceContact
Info
Daniel WagnerConnecticut InnovationsManaging Director, Investments000 0000
Gerald VovisCMDBioscienceBoard Member000 0000
Joseph Audie Ph.DCMDBioscienceChief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member000 0000
Konstantine DrakonakisLaunchCapitalDirector000 0000
Daniel Wagner Managing Director, Investments Connecticut Innovations
Gerald Vovis Board Member CMDBioscience
Joseph Audie Ph.D Chief Executive Officer, Chief Strategy Officer, Co-Founder & Board Member CMDBioscience
Konstantine Drakonakis Director LaunchCapital
Request full access to PitchBook